Porphyromonas gingivalis-Lipopolysaccharide Induced Caspase-4 Dependent Noncanonical Inflammasome Activation Drives Alzheimer’s Disease Pathologies
Open Access
Abstract
Chronic periodontitis, driven by the keystone pathogen Porphyromonas gingivalis, has been increasingly associated with Alzheimer’s disease (AD) and AD-related dementias (ADRDs). However, the mechanisms through which P. gingivalis-lipopolysaccharide (LPS)-induced release of neuroinflammatory proteins contribute to the pathogenesis of AD and ADRD remain inadequately understood. Caspase-4, a critical mediator of neuroinflammation, plays a pivotal role in these processes following exposure to P. gingivalis-LPS. In this study, we investigated the mechanistic role of caspase-4 in P. gingivalis-LPS-induced IL-1β production, neuroinflammation, oxidative stress, and mitochondrial alterations in human neuronal and microglial cell lines. Silencing of caspase-4 significantly attenuated IL-1β secretion by inhibiting the activation of the caspase-4-NLRP3-caspase-1-gasdermin D inflammasome pathway, confirming its role in neuroinflammation. Moreover, caspase-4 silencing reduced the activation of amyloid precursor protein and presenilin-1, as well as the secretion of amyloid-β peptides, suggesting a role for caspase-4 in amyloidogenesis. Caspase-4 inhibition also restored the expression of key neuroinflammatory markers, such as total tau, VEGF, TGF, and IL-6, highlighting its central role in regulating neuroinflammatory processes. Furthermore, caspase-4 modulated oxidative stress by regulating reactive oxygen species production and reducing oxidative stress markers like inducible nitric oxide synthase and 4-hydroxynonenal. Additionally, caspase-4 influenced mitochondrial membrane potential, mitochondrial biogenesis, fission, fusion, mitochondrial respiration, and ATP production, all of which were impaired by P. gingivalis-LPS but restored with caspase-4 inhibition. These findings provide novel insights into the role of caspase-4 in P. gingivalis-LPS-induced neuroinflammation, oxidative stress, and mitochondrial dysfunction, demonstrating caspase-4 as a potential therapeutic target for neurodegenerative conditions associated with AD and related dementias.Keywords
Funding Information
- National Institute on Aging (NIA) (P30AG28718)
This publication has 85 references indexed in Scilit:
- Cardiac-specific overexpression of serum response factor regulates age-associated decline in mitochondrial functionGeroScience, 2025
- Reelin links Apolipoprotein E4, Tau, and Amyloid‐β in Alzheimer’s diseaseAgeing Research Reviews, 2024
- Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammation in SH-SY5Y and HMC3 cellsGeroScience, 2024
- Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neuronsActa Neuropathologica, 2022
- Lipopolysaccharide-induced inflammation increases nitric oxide production in taste budsBrain, Behavior, and Immunity, 2022
- Contribution of Porphyromonas gingivalis lipopolysaccharide to experimental periodontitis in relation to agingGeroScience, 2020
- Effects of Porphyromonas gingivalis and Its Underlying Mechanisms on Alzheimer-Like Tau Hyperphosphorylation in Sprague-Dawley RatsJournal of Molecular Neuroscience, 2020
- Porphyromonas gingivalis and Alzheimer disease: Recent findings and potential therapiesJournal of Periodontology, 2020
- Inflammasome Complexes: Emerging Mechanisms and Effector FunctionsCell, 2016
- Caspase‐11 activates a canonical NLRP3 inflammasome by promoting K+ effluxEuropean Journal of Immunology, 2015